Tech Company Financing Transactions
Cormatrix Cardiovascular Funding Round
Private investors participated in a $24.6 million funding round for Cormatrix Cardiovascular. The round was announced on 10/18/2013.
Transaction Overview
Company Name
Announced On
10/18/2013
Transaction Type
Venture Equity
Amount
$24,610,032
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1100 Old Ellis Rd.
Roswell, GA 30076
USA
Roswell, GA 30076
USA
Phone
Website
Email Address
Overview
CorMatrix s patented extracellular matrix (ECM) supports adaptive tissue regeneration and remodeling of essential anatomy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Edgar Rey
Chief Scientific Officer
Robert Matheny
Browse more venture capital transactions:
Prev: 10/18/2013: AppLift venture capital transaction
Next: 10/18/2013: Clinical Ink venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs